期刊文献+

卵巢浆液性癌三年生存预后因素的分类树分析 被引量:1

Classification tree analysis in serous ovarian adenocarcinoma patients for prognostic factors associated with three-year survival probability
原文传递
导出
摘要 目的应用分类树模型探讨影响卵巢浆液性癌3年生存的预后因素。方法收集1991年1月—2003年12月北京大学人民医院初次收治、随诊3年并已有临床结局的81例卵巢浆液性癌患者的临床资料,采用分类与回归树(CART)软件建立分类树模型,评价预后因素。结果采用CART软件建立的分类树模型中,年龄是影响卵巢浆液性癌3年生存的最重要的预后因素,其他预后因素包括:手术病理分期、淋巴结转移、术后残余病灶、术后化疗方法及病理分级。替代变量分析显示,手术病理分期和淋巴结转移是年龄的主要替代变量。结论年龄、手术病理分期、淋巴结转移、术后残余病灶、术后化疗方法及病理分级是影响卵巢浆液性癌3年生存预后的主要因素。 Objective To analyze the prognostic factors associated with three-year survival outcome in patients with serous ovarian adenocarcinoma by classification tree. Methods Retrospectively we analyzed 81 cases with serous ovarian adenocarcinoma who had 3-year clinical outcomes and were hospitalized in People's Hospital from Jan 1991 to Dec 2003 by classification and regression trees (CART) software. Establish the classification tree. Results Among the factors that were associated with the 3-year survival rate, age was the most important factor, other factors in turn were International Federation of Gynecology and Obstetrics (FIGO) stage, lymphoid metastasis, residual size after operation, chemotherapy and pathologic grade. By substitution variable analysis, it was demonstrated that there was cross interaction between age and residual size as well as age and chemotherapy. Conclusion Age, FIGO stage, lymphoid metastasis, residual size after operation, chemotherapy and pathologic grade are important prognostic factors related with three-year survival probability of serous ovarian adenocarcinoma patients.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2008年第3期201-204,共4页 Chinese Journal of Obstetrics and Gynecology
基金 北京大学医学部“985工程”二期建设项目(985-2-015-24)
关键词 卵巢肿瘤 囊腺癌 浆液 存活率分析 模型 统计学 预后 Ovarian neoplasms Cystadenocarcinoma, serous Survival analysis Models, statistical Prognosis
  • 相关文献

参考文献9

  • 1McGuire V, Jesser CA, Whittemore AS. Survival among U. S. women with invasive epithelial ovarian cancer. Gynecol Oncol, 2002, 84:399-403.
  • 2De Laurentiis M, De Placido S, Bianeo AR, et al. A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients. Clin Cancer Res, 1999, 5: 4133-4139.
  • 3张颖,倪宗瓒,姚树祥,巫秀美,姜勇,李晓松,乔友林.树型分类及其应用[J].中国卫生统计,2000,17(5):272-275. 被引量:8
  • 4杨蓉,冯捷,房祥忠,白符,成夜霞,刘晨,朱炜,李林.卵巢浆液性腺癌预后评分模型的建立及应用[J].中华妇产科杂志,2006,41(7):459-463. 被引量:10
  • 5Hoskins WJ, Bundy BN, Thigpen JT, et al. The influence of cytoreductive surgery on recurrence-free interval and survival in small volume stage Ⅲ epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol, 1992,47:159-166.
  • 6Polverino G, Parazzini F, Stellato G, et al. Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin-paclitaxel chemotherapy. Gynecol Oncol, 2005,99 : 343-347.
  • 7Hightower RD, Nguyen HN, Averette HE, et al. National survey of ovarian carcinoma. Ⅳ: Patterns of care and related survival for older patients. Cancer, 1994, 73:377-383.
  • 8Ganz PA. Does (or should) chronologic age influence the choice of cancer treatment? Oncology, 1992, 6 (2 Suppl) :45-49.
  • 9Markman M, Lewis JL, Saigo P, et al. Impact of age on survival of patients with ovarian cancer. Gynecol Oncol, 1993, 49: 236-239.

二级参考文献11

  • 1耿京,崔恒,魏丽惠,钱和年.TP、PTP及CAP化疗方案治疗上皮性卵巢癌的比较[J].中国妇产科临床杂志,2001,2(5):283-285. 被引量:2
  • 2Clark TG, Stewart ME, Altman DG, et al. A prognostic model for ovarian cancer. Br J Cancer, 2001,85:944-952.
  • 3De Laurentiis M, De Plaeido S, Bianeo AR, et al. A prognostic model that makes quantitative estimates of probability of relapse for breast cancer patients. Clin Cancer Res, 1999, 5:4133-4139.
  • 4Linasmita V, Pattaraarchachai J, Daengdeelert P. Prognostic factors for survival of epithelial ovarian cancer, lnt J Gynecol Obstet, 2004,85:66-69.
  • 5Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gyneeol Oneol,1998, 69:103-108.
  • 6Brinkhuis M, Meijer GA, Baak JP. An evaluation of prognostic factors in advanced ovarian cancer. Eur J Obstet Gynecol Reprod Biol, 1995, 63 : 115-124.
  • 7Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol, 2002, 20: 1248-1259.
  • 8Bristow RE, Montz FJ, Lagasse LD, et al. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol, 1999, 72:278-287.
  • 9Zhang Heping,Am J Epidemiol,1996年,144卷,10期,70页
  • 10于石成,博士学位论文,1996年

共引文献16

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部